High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1992-1999

  Mwatha, Joseph K ^a   Kimani, Gachuhi ^a   Kamau, Timothy ^a   Mbugua, Gabriel G ^a   Ouma, John H ^a   Mumo, Jasper ^a   Fulford, Anthony J C ^b   Jones, Frances M ^b   Butterworth, Anthony E ^b   Roberts, Morven B ^b   Dunne, David W ^b  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 5; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TREMATODE;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-5; LIVER DISEASES, PARASITIC; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; SCHISTOSOMIASIS MANSONI; SPLENIC DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032519928     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Boros, D. L. 1994. The role of cytokines in formation of the schistosome egg granuloma. Immunobiology 191:441.
2. Doehring-Schwerdtfeger, E., I. M. Abdel-Rahim, Q. Mohamed-Ali, M. Elsheikh, J. Schlake, R. Kardorff, D. Franke, C. Kaiser, and J. H. H. Ehrich. 1990. Ultra-sonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: evaluation of morbidity. Am. J. Trop. Med. Hyg. 42:581.
3. Gryseels, B., and A. M. Polderman. 1987. The morbidity of schistosomiasis mansoni in Maniema (Zaire). Trans. R. Soc. Trop. Med. Hyg. 81:202.
4. Kardorff, R., M. Traore, A. Diarra, M. Sacko, M. Maiga, D. Franke, U. Vester, U. Hansen, H. A. Traore, S. Fongoro, H. Gorgen, R. Korte, B. Gryseels, E. Doehring-Schwerdtfeger, and J. H. H. Ehrich. 1994. Lack of ultrasonographic evidence for severe hepatosplenic morbidity in schistosomiasis mansoni in Mali. Am. J. Trop. Med. Hyg. 51:190.
5. Siongok, T. K. A., A. A. F. Mahmoud, J. H. Ouma, K. S. Warren, A. K. Muller, A. K. Hander, and H. B. Houser. 1976. Morbidity in schistosomiasis mansoni in relation to intensity of infection: study of a community in Kisumu, Kenya. Am. J. Trop. Med. Hyg. 25:273.
6. Fulford, A. J. C., G. G. Mbugua, J. H. Ouma, H. C. Kariuki, R. F. Sturrock, and A. E. Butterworth. 1991. Differences in the rate of hepatosplenomegaly due to Schistosoma mansoni infection between two areas in Machakos district, Kenya. Trans. R. Soc. Trop. Med. Hyg. 85:481.
7. Wynn, T. A., and A. W. Cheever. 1995. Cytokine regulation of granuloma formation in schistosomiasis. Curr. Opin. Immunol. 7:505.
8. Mathew, R. C., and D. L. Boros. 1986. Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin 2 production in Schistosoma mansoni infection. Infect. Immun. 54:820.
9. Grzych, J. M., E. J. Pearce, A. Cheever, Z. A. Caulada, P. Caspar, S. Heiny, F. Lewis, and A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 147:3921.
10. Pearce, E. J., P. Casper, J. M. Grzych, F. A. Lewis, and A. Sher. 1991. Down-regulation of TH1 cytokine production accompanies induction of TH2 responses by a helminth. Schistosoma mansoni. J. Exp. Med. 173:159.
11. + Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J. Immunol. 148:2283.
12. Yamashita, T., and D. L. Boros. 1992. IL-4 influences IL-2 production and granulomatous inflammation in murine schistosomiasis mansoni. J. Immunol. 149: 1430.
13. Chensue, S. W., P. D. Terebuh, K. S. Warmington, S. D. Hershey, H. L. Evanoff, S. L. Kunkel, and G. I. Higashi. 1992. Role of interleukin-4 and gamma-interferon in Schistosoma mansoni egg-induced hypersensitivity granuloma formation: orchestration, relative contribution, and relationship to macrophage function. J. Immunol. 148:900.
14. Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Guase, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430.
15. Lukacs, N. W., and D. L. Boros. 1993. Lymphokine regulation of granuloma formation in murine schistosomiasis mansoni. J. Immunol. 68:57.
16. Cheever, A. W., M. E. Williams, T. A. Wynn, F. D. Finkelman, R. A. Seder, T. M. Cox, S. Hieny, P. Casper, and A. Sher. 1994. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 153:753.
17. Wynn, T. A., I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher. 1994. Endogenous interleukin 12 (IL12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL12 both inhibits and prophylactically immunises against egg pathology. J. Exp. Med. 179:1551.
18. Wynn, T. A., D. Jankovic, S. Hieny, K. Zioncheck, P. Jardieu, A. W. Cheever, and A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154:3999.
19. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Casper, F. A. Lewis, and A. Sher. 1995. An IL12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594.
20. Joseph, A. L., and D. L. Boros. 1993. Tumour necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J. Immunol. 151:5461.
21. Amiri P., R. M. Locksley, D. G. Parslow, M. Sadick, E. Rector, D. Ritter, and J. H. McKerrow. 1992. Tumour necrosis factor restores granulomas and induces parasite egg laying in schistosome infected SCID mice. Nature 356:604.
22. Adewusi, O. I., N. A. Nix, X. Lu, D. G. Colley, and W. E. Secor. 1996. Schistosoma mansoni: relationship of tumor necrosis factor-α to morbidity and collagen deposition in chronic experimental infection. Exp. Parasitol. 84:115.
23. Leptak, C. L., and J. H. McKerrow. 1997. Schistosomiasis egg granuloma and hepatic expression of TNF-α are dependent on immune priming during parasite maturation. J. Immunol. 158:301.
24. Lukacs, N. W., S. W. Chensue, R. M. Strieter, K. Warmington, and S. L. Kunkel. 1994. Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1. J. Immunol. 152:5883.
25. Wiest, P. M. 1996. The epidemiology of morbidity of schistosomiasis. Parasitol. Today 12:215.
26. Zwingenberger, K., E. Irschick, J. G. Siqueira Vergetti, A. R. Correia Dacal, R. Janssen-Rosseck, U. Bienzle, C. Huber, and H. Feldmeier. 1989. Release of interleukin-2 and gamma interferon by peripheral mononuclear cells in human Schistosoma mansoni infection normalizes after chemotherapy. Scand. J. Immunol. 30:463.
27. Butterworth, A. E., E. L. Corbett, D. W. Dunne, A. J. C. Fulford, G. Kimani, R. K. Klump, G. Mbugua, J. H. Ouma, T. K. Siongok, and R. F. Sturrock. 1989. Immunity and morbidity in human schistosomiasis mansoni. In New Strategies in Parasitology. K. P. W. J. McAdam, ed. Churchill Livingstone, Edinburgh, p. 193.
28. Bahia-Oliveira, L. M. G., G. Gazzinelli, S. M. Eloi-Santos, J. R. Cunha-Melo, L. F. Alves-Oliveira, A. M. S. Silveira, I. R. C. Viana, J. Carmo, A. Souza, and R. Correa-Oliveira. 1992. Differential cellular reactivity to adult worm antigens of patients with different clinical forms of schistosomiasis mansoni. Trans. R. Soc. Trop. Med. Hyg. 86:57.
29. Bahia-Oliveira, L. M. G., A. J. G. Simpson, L. F. Alves-Oliveira, C. Carvalho-Queiroz, A. M. S. Silveira, I. R. C. Viana, J. R. Cunha-Melo, P. Hagan, G. Gazzinelli, and R. Correa-Oliveira. 1996. Evidence that cellular immune responses to soluble and membrane associated antigens are independently regulated during human schistosomiasis mansoni. Parasite Immunol. 18: 53.
30. Williams, M. E., S. Montenegro, A. L. Domingues, T. A. Wynn, K. Teixeira, S. Mahanty, A. Coutinho, and A. Sher. 1994. Leukocytes of patients with Schistosoma mansoni respond with a TH2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens. J. Infect. Dis. 170:946.
31. Zwingenberger, K., E. Irschick, J. G. Vergetti Siqueira, A. R. Correia Dacal, and H. Feldmeier. 1990. Tumour necrosis factor in hepatosplenic schistosomiasis. Scand. J. Immunol. 31:205.
32. Raziuddin, S., M. Masihuzzaman, S. Shetty, and A. Ibrahim. 1993. Tumor necrosis factor alpha production in schistosomiasis with carcinoma of urinary bladder. J. Clin. Immunol. 13:23.
33. Azim, A. A., H. A. Sedky, M. A. El-Tahawy, A. A. Fikry, and H. Mostafa. 1995. Serum levels of tumor necrosis factor in different stages of schistosomal infection. J. Egypt. Soc. Parasitol. 25:279.
34. Khalil, H. M., A. G. El-Missiry, H. M. F. Abdalla, N. M. Khalil, N. M. Sabry, H. E. Abdel-Atty, F. A. Tamara, M. El-Tayeb, and N. M. Zakaria. 1995. Serum levels of tumour necrosis factor-alpha in schistosomiasis mansoni and their analogous changes in collagen diseases and schistosomal arthropathy. J. Egypt. Soc. Parasitol. 25:427.
35. Secor, W. E., G. R. Mittermayer, E. A. G. Ramos, E. P. Matos, E. A. G. Reis, T. M. A. Carmo, and D. A. Harn. 1994. Soluble intercellular adhesion molecules in human schistosomiasis: correlations with disease severity and decreased responsiveness to egg antigens. Infect. Immun. 63:2695.
36. Dunne, D. W., A. E. Butterworth, A. J. C. Fulford, H. C. Kariuki, J. G. Langley, J. H. Ouma, A. Capron, R. J. Pierce, and R. F. Sturrock. 1992. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22:1483.
37. Roberts, M., A. E. Butterworth, K. Gachuhi, T. Kamau, A. J. C. Fulford, D. W. Dunne, J. H. Ouma, R. F. Sturrock. 1993. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to re-infection. Infect. Immun. 61:4984.
38. Mossman, T. R. 1991. Cytokine secretion patterns and cross-regulation of T cell subsets. regulation of immune responses by T cells with different cytokine secretion phenotypes: role of a new cytokine, cytokine synthesis inhibitory factor (IL10). Immunol. Res. 10:183.
39. Van Deuren, M. 1994. Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections. Eur. J. Clin. Microbiol. Infect. Dis. 13:S12.
40. Corbett, E. L., A. E. Butterworth, A. J. C. Fulford, J. H. Ouma, and R. F. Sturrock. 1992. Nutritional status of children with schistosomiasis mansoni in two different areas of Machakos district, Kenya. Trans. R. Soc. Trop. Med. Hyg. 86:266.
41. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
42. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571.
43. Essner, R., K. Rhoades, W. H. McBride, D. L. Morton, and J. S. Economou. 1989. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142:3857.
44. Chensue, S. W., K. S. Warmington, J. H. Ruth, P. Lincoln, and S. L. Kunkel. 1995. Cytokine function during mycobacterial and schistosomal antigen-induced granuloma formation: local and regional participation of IFN-gamma, IL-10 and TNF. J. Immunol. 154:5969.
45. Henderson, G. S., N. A. Nix, M. A. Montesano, D. Gold, G. L. Freeman, T. L. McCurley, and D. G. Colley. 1993. Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni. Am. J. Pathol. 142: 703.
46. Rosa Brunet, L., F. D. Finkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce. 1997. IL-4 projects against TNF-α mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:777.
47. Piguet, P. F., M. A. Collart, G. E. Grau, A. P. Sappino, and P. Vassalli. 1990. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344:245.
48. Miyazaki, Y., K. Araki, C. Vesin, I. Garcia, Y. Kapanci, J. A. Whitsett, P. F. Piguet, and P. Vassalli. 1995. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis: a mouse model of progressive pulmonary fibrosis. J. Clin. Invest. 96:250.
49. Piguet, P. F., S. Kaufman, C. Barazzone, M. Muller, B. Ryffel, and H. P. Eugster. 1997. Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis. Int. J. Exp. Path. 78:43.
50. Zijlstra, E. E., T. Van der Poll, and M. Mevissen. 1995. Soluble receptors for tumor necrosis factor as markers of disease activity in visceral leishmaniasis. J. Infect. Dis. 171:498.
51. Kawaguchi, H., Y. Ina, S. Ito, S. Sato, Y. Sugiura, H. Tomita, N. Ogisu, K. Takada, M. Yamamoto, M. Morishita, and K. Yoshikawa. 1996. Serum levels of soluble tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis. Kekkaku 71:259.
52. Godfried, M. H., J. A. Romijn, T. Van der Poll, G. J. Weverling, E. P. M. Corssmit, E. Endert, J. K. E. Schattenkerk, and H. P. Sauerwein. 1995. Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection. Metabol. Clin. Exp. 44:1564.
53. Kern, W . V, J. Oristrell, F. Segura Porta, and P. Kern. 1996. Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis. Clin. Diagn. Lab. Immunol. 3:233.
54. Gadducci, A., M. Ferdeghini, C. Castellani, C. Annicchiarico, O. Gagetti, C. Prontera, R. Bianchi, and V. Facchini. 1995. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. Gynecol. Oncol. 58:184.
55. Barrera, P., C. J. Haagsma, A. M. Th. Boerbooms, P. L. C. M. Van Riel, G. F. Borm, L. B. A. Van De Putte, and J. W. M. Van Der Meer. 1995. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists: longitudinal evaluation in patients with rheumatoid arthritis. Br. J. Rheumatol. 34:747.
56. Ulich, T. R., E. S. Yi, S. Yin, C. Smith, and D. Remick. 1994. Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. Clin. Immunol. Immunopathol. 72:137.
57. Laichalk, L. L., S. L. Kunkel, R. M. Strieter, J. M. Danforth, M. B. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defence in murine Klebsiella pneumonia. Infect. Immun. 64:5211.
58. Wee, S., M. Pascual, J. D. Eason, D. A. Schoenfeld, J. Phelan, S. Boskovic, C. Blosch, K. Mohler, and A. B. Cosimi. 1997. Biological effects and fate of a soluble, dimeric, 80-kDa tumor necrosis factor receptor in renal transplant recipients who receive OKT3 therapy 1. Transplantation 63:570.
59. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:323.
60. Josimovic-Alasevic, O., H. Feldmeier, K. Zwingenberger, G. Harms, H. Hahn, and T. Diamantstein. 1988. IL2-receptor in systemic parasitic disease. Clin. Exp. Immunol. 72:249.
61. Ritter, D. M., and J. H. McKerrow. 1996. Intercellular adhesion molecule 1 is the major adhesion molecule expressed during schistosome granuloma formation. Infect. Immun. 64:4706.